New: NCI-funded clinical trial search
Mednet Logo
SpecialtiesRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

How do you approach a young patient with metastatic poorly differentiated thyroid cancer with rhabdoid/non-anaplastic features?

4
4 Answers

Mednet Member
Mednet Member
Medical Oncology · University of Michigan Medical School

Unfortunately, this patient has a very poor prognosis. Due to the nature of her tumor being poorly differentiated, her disease is more likely than not to be refractory to radioiodine. If her disease in the thyroid and neck has not been addressed, external beam radiation therapy should be offered for...

Can a nonbulky, T1-2 supraglottic larynx cancer near the vocal cords be treated like a glottic tumor?

4
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Maryland School of Medicine

The supraglottic larynx and the pharynx, unlike the glottic larynx, share similar embryological origins and therefore exhibit analogous lymphatic drainage patterns to levels II and III. Therefore, occult dissemination to regional lymph nodes has to be considered regardless of the characteristics of ...

Do you use nomograms to decide whether to treat pelvic nodes in high-intermediate to high risk prostate cancer?

1
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Rather than using risk estimate, my practice is to treat nodes for all high risk patients unless there is a contraindication. The nodal group I treat is distal common iliac, external, internal iliac, obturator and presacral region. The contouring principal is same for all pelvic malignancies and is ...

For a patient with stage IIB pure seminoma s/p orchiectomy who has bilateral RP adenopathy, do you also cover the contralateral iliac nodes in the dog-leg field?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

I would treat ipsilateral pelvic node only Wilder et al., PMID 22436787

What is the role of GammaTile in the management of primary brain tumors and brain metastases?

3
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · UPMC Hillman Cancer Center

GammaTiles are an intracranial brachytherapy product marketed by GT Medical Technologies consisting of a Cs-131 source imbedded within a collagen matrix. Proponents of the technology argue that advantages of GammaTiles over external beam radiotherapy techniques include the ability to “start” the rad...

Is it acceptable to use once daily fractionation for small cell lung cancer?

10
7 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Pennsylvania Health System

This question is still very relevant of further discussion. This particular poll and commentary began in June 2016! For the record, as of today I still prefer 45 Gy in 30 fractions delivered BID. For those that cannot come to treatment twice-daily, I use 60-66 Gy in 30-33 fractions based on OAR cons...

Do you consider ablative radiation therapy for oligometastatic colon cancer with 5 pulmonary lesions responding to chemotherapy?

3
2 Answers

Mednet Member
Mednet Member
Medical Oncology · Mayo Clinic

The definition of oligometastatic colorectal cancer (OCRC) varies quite significantly. The European Society for Medical Oncology (ESMO) defines OCRC as having up to five lesions in no more than three metastatic sites but can sometimes have more if complete eradication is possible. There is no random...

What pentoxifylline and vitamin E dose do you typically use for both the prevention and treatment of radiation-associated fibrosis after breast RT?

7
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Arizona

Pentoxifylline 400 mg three times daily and Vit E 400 iU once daily.In a small retrospective review, tolerance to Pentoxifylline was improved with the use of concurrent antiemetic therapy. Of those on antiemetic therapy, 89% completed pentoxifylline as prescribed versus 48% of those without antiemet...

Do you offer memantine for patients undergoing PCI?

5
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems

Extrapalating on 0614, I do use memantine for patients undergoing PCI. I do this for 6 months. These are patients that are expected to live even longer than brain met patients. And given the low toxicity, I think it would be rude not too (as one of my former students would say!)

Is there a role for prophylactic Trental and vitamin E in a patient at high risk for osteoradionecrosis?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Florida

Probably not